Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness

Head and Neck

Volumn 34, Issue 1, 2012, Pages 42-49

  Joshua, Benzion ^a   Kaplan, Michael J ^a   Doweck, Ilana ^b   Pai, Reetesh ^c   Weissman, Irving L ^c   Prince, Mark E ^d   Ailles, Laurie E ^e  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b CARMEL MEDICAL CENTER   (Israel)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

cancer; CD44; head and neck; squamous cell carcinoma; stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; HERMES ANTIGEN;

ADULT; AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CELL LINEAGE; CONTROLLED STUDY; FEMALE; FIBULA GRAFT; GLOSSECTOMY; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MALE; MOUSE; MOUTH CARCINOMA; NECK DISSECTION; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR XENOGRAFT;

ADULT; ANIMALS; ANTIGENS, CD44; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 83555172386     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21699     Document Type: Article

References (38)

1. Jain S, Khuri FR, Shin DM,. Prevention of head and neck cancer: current status and future prospects. Curr Probl Cancer 2004; 28: 265-286. (Pubitemid 39208737)
2. Lee JT, Ko CY,. Has survival improved for nasopharyngeal carcinoma in the United States? Otolaryngol Head Neck Surg 2005; 132: 303-308. (Pubitemid 40431149)
3. Golas SM,. Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol 2007; 35: 98-108.
4. Gupta S, Kong W, Peng Y, Miao Q, Mackillop WJ,. Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer 2009; 125: 2159-2165.
5. Pardal R, Clarke MF, Morrison SJ,. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902. (Pubitemid 37500174)
6. Reya T, Morrison SJ, Clarke MF, Weissman IL,. Stem cells, cancer, and cancer stem cells. Nature 2001; 414 (6859): 105-111. (Pubitemid 33041634)
7. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ,. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997; 89: 3104-3112. (Pubitemid 27229792)
8. Bonnet D, Dick JE,. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737. (Pubitemid 27298715)
9. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-667. (Pubitemid 39063268)
10. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367 (6464): 645-648. (Pubitemid 24067706)
11. Miyamoto T, Weissman IL, Akashi K,. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A 2000; 97: 7521-7526. (Pubitemid 30431496)
12. Ailles LE, Weissman IL,. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18: 460-466. (Pubitemid 350116595)
13. Rosen JM, Jordan CT,. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324 (5935): 1670-1673.
14. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ,. Efficient tumour formation by single human melanoma cells. Nature 2008; 456 (7222): 593-598.
15. Shackleton M, Quintana E, Fearon ER, Morrison SJ,. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822-829.
16. Gupta PB, Chaffer CL, Weinberg RA,. Cancer stem cells: mirage or reality? Nat Med 2009; 15: 1010-1012.
17. Robbins KT, Doweck I, Samant S, Vieira F, Kumar P,. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 2004; 114: 411-417. (Pubitemid 38391901)
18. Massano J, Regateiro FS, Januario G, Ferreira A,. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67-76. (Pubitemid 44016111)
19. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007; 356: 217-226. (Pubitemid 46143225)
20. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978. (Pubitemid 46154721)
21. Ailles L, Prince M,. Cancer stem cells in head and neck squamous cell carcinoma. Methods. Mol Biol 2009; 568: 175-193.
22. Locke M, Heywood M, Fawell S, Mackenzie IC,. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 2005; 65: 8944-8950. (Pubitemid 41377385)
23. Nelson AD, Grandis JR,. The role of CD44 in HNSCC. Cancer Biol Ther 2007; 6: 125-126. (Pubitemid 46294194)
24. Ponta H, Sherman L, Herrlich PA,. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4: 33-45. (Pubitemid 36077255)
25. Bankfalvi A, Krassort M, Buchwalow IB, Vegh A, Felszeghy E, Piffko J,. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 2002; 198: 343-351. (Pubitemid 35277385)
26. Carinci F, Stabellini G, Calvitti M, et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 2002; 13: 85-89. (Pubitemid 34873952)
27. Gonzalez-Moles MA, Bravo M, Ruiz-Avila I, et al. Adhesion molecule CD44 as a prognostic factor in tongue cancer. Anticancer Res 2003; 23 (6D): 5197-202. (Pubitemid 38182146)
28. Gonzalez-Moles MA, Gil-Montoya JA, Ruiz-Avila I, Esteban F, Delgado-Rodriguez M, Bascones-Martinez A,. Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. Oncol Rep 2007; 18: 389-396.
29. Kosunen A, Pirinen R, Ropponen K, et al. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol 2007; 43: 51-59. (Pubitemid 46162248)
30. Kuo MY, Cheng SJ, Chen HM, Kok SH, Hahn LJ, Chiang CP,. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1998; 27: 428-433. (Pubitemid 28490131)
31. Masuda M, Kuratomi Y, Shiratsuchi H, Nakashima T, Naonobu K, Komiyama S,. Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy. Head Neck 2000; 22: 662-665.
32. Qin G, Li W, Sun X, Zhu L, Chen Z,. [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005; 19: 688-691.
33. Sato S, Miyauchi M, Takekoshi T, et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 2000; 36: 545-549.
34. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P, Lohrs U,. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 1999; 35: 484-489. (Pubitemid 29386784)
35. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY,. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009; 119: 1518-1530.
36. Mack B, Gires O,. CD44s and CD44v6 expression in head and neck epithelia. PLoS One 2008; 3: e3360.
37. Clay MR, Tabor M, Owen JH, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-1201.
38. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-313.